Immunocore Holdings Plc (IMCR) Inventory Turnover Ratio, from third quarter 2026 to third quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 
Immunocore Holdings Plc  (NASDAQ: IMCR)
 

Immunocore Holdings Plc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Immunocore Holdings Plc's inventory turnover ratio, the ratio that measures Immunocore Holdings Plc's ability to manage its supply chain, sequentially decreased to 0.65 in the third quarter 2026, but it does not raise any concerns as Immunocore Holdings Plc continue to execute well, and the inventory turnover ratio remains above the average. Immunocore Holdings Plc's average inventory processing period in the Sep 30 2026 quarter, has increased to 562 days, from 545 days, in the Jun 30 2026 quarter.

Within Healthcare sector 343 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1576 in the second quarter 2026, to 1886.

IMCR Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Immunocore Holdings Plc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

IMCR Inventory Turnover Ratio (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Inventory Growth 32.04 % 42.8 % 21.3 % 23.8 % 25.17 %
Y / Y Cost of Sales Growth 31.77 % 4.62 % -47.77 % 719.09 % 14.51 %
Inventory Turnover Ratio (TTM) 0.65 0.67 0.72 0.83 0.46
IMCR's Total Ranking # 1886 # 1576 # 1518 # 1636 #
Average inventory processing period 563 548 508 442 785
Seq. Inventory Growth -4.16 % -5.6 % 22.41 % 19.22 % 3.65 %
Seq. Cost of Sales Growth -37.87 % 150.69 % -83.94 % 426.9 % -50.67 %




Inventory Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 26
Healthcare Sector # 344
Overall Market # 1886

Inventory Turnover Ratio Statistics
High Average Low
0.83 0.63 0.46
(Dec 31 2025)   (Sep 30 2025)



IMCR Company Profile >> Back to IMCR Efficiency Comparisons >> Compare IMCR Inventory Turnover Ratio to its Competitors

Financial Statements
Immunocore Holdings Plc's Inventories $ 7 Millions Visit IMCR's Balance sheet
Immunocore Holdings Plc's Cost of Revenues TTM $ 5 Millions Visit IMCR's Income Statement
What are IMCR's Sales? Visit IMCR's Sales by Segment

Other Inventory Turnover Ratios
Immunocore Holdings Plc's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Biotechnology & Pharmaceuticals Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
IMCR's Inventory Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for IMCR's Competitors
Inventory Turnover Ratio for IMCR's Suppliers
Inventory Turnover Ratio for IMCR's Customers

You may also want to know
IMCR's Sales Growth Rates IMCR's Pe Price to earnings ratio IMCR's Receivables Turnover Ratio IMCR's Stock Quote
IMCR's Net Income Growth Rates IMCR's Ps Price to Sales ratio IMCR's Sales per Employee IMCR's Asset Turnover Ratio
IMCR's Net Margin IMCR's Pb Price to Book ratio IMCR's Financial Strength Ratios IMCR's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2026 Inventories at quarter ending Sep 30 2026
Iradimed Corporation  1.78 $ 21.878  Millions$ 12  Millions
Ceribell Inc   1.74 $ 12.160  Millions$ 7  Millions
Axsome Therapeutics Inc   1.67 $ 58.422  Millions$ 35  Millions
Insmed Inc  1.66 $ 237.067  Millions$ 143  Millions
Stryker Corp  1.66 $ 9,116.000  Millions$ 5,499  Millions
Pfizer Inc  1.64 $ 16,940.000  Millions$ 10,322  Millions
Integra Lifesciences Holdings Corp  1.62 $ 789.329  Millions$ 486  Millions
Conmed Corporation  1.61 $ 580.951  Millions$ 361  Millions
Axogen inc   1.49 $ 68.923  Millions$ 46  Millions
Aurinia Pharmaceuticals Inc   1.29 $ 30.165  Millions$ 23  Millions
Pulmonx Corporation  1.28 $ 20.450  Millions$ 16  Millions
Alphatec Holdings Inc   1.27 $ 241.341  Millions$ 189  Millions
Si bone inc   1.25 $ 46.999  Millions$ 38  Millions
Bridgebio Pharma Inc   1.24 $ 53.542  Millions$ 43  Millions
Biogen Inc   1.23 $ 2,681.800  Millions$ 2,181  Millions
Kiniksa Pharmaceuticals International Plc  1.21 $ 93.072  Millions$ 77  Millions
Rhythm Pharmaceuticals Inc   1.14 $ 33.056  Millions$ 29  Millions
Penumbra Inc  1.13 $ 499.548  Millions$ 443  Millions
Corcept Therapeutics Inc  1.11 $ 14.097  Millions$ 13  Millions
Alkermes Plc   1.10 $ 300.119  Millions$ 273  Millions
Neurocrine Biosciences Inc   1.07 $ 81.200  Millions$ 76  Millions
Emergent Biosolutions Inc   1.07 $ 334.800  Millions$ 314  Millions
Vertex Pharmaceuticals Inc  1.00 $ 1,874.100  Millions$ 1,866  Millions
Amarin Corp Plcuk  0.92 $ 104.502  Millions$ 113  Millions
Eli Lilly And Company  0.89 $ 14,149.700  Millions$ 15,815  Millions
Cerus Corporation  0.87 $ 54.000  Millions$ 62  Millions
Rxsight Inc   0.82 $ 29.342  Millions$ 36  Millions
Inspire Medical Systems inc   0.74 $ 122.959  Millions$ 165  Millions
Butterfly Network Inc   0.62 $ 37.120  Millions$ 60  Millions
Regeneron Pharmaceuticals Inc   0.60 $ 1,842.200  Millions$ 3,071  Millions

Date modified: 2026-11-07T05:36:21+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.